Publications by authors named "Sara Fuchs"

Claim this Profile
M
MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance.
Debby Reuveni, Revital Aricha, Miriam C Souroujon, Sara Fuchs

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
Revital Aricha, Debby Reuveni, Sara Fuchs, Miriam C Souroujon

J Autoimmun· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.
Julia Miriam Weiss, Marieke Robinet, Revital Aricha, Perrine Cufi, Bérengère Villeret, Sara Fuchs

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis.
Marie Maurer, Sylvain Bougoin, Tali Feferman, Mélinée Frenkian, Jacky Bismuth, Sara Fuchs

Acta Neuropathol Commun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
Sara Fuchs, Revital Aricha, Debby Reuveni, Miriam C Souroujon

J Autoimmun· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age dependent course of EAE in Aire-/- mice.
Rina Aharoni, Revital Aricha, Raya Eilam, Ido From, Keren Mizrahi, Sara Fuchs

J Neuroimmunol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model.
Smadar Gertel-Lapter, Keren Mizrachi, Sonia Berrih-Aknin, Sara Fuchs, Miriam C Souroujon

Autoimmun Rev· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Miriam C Souroujon, Revital Aricha, Tali Feferman, Keren Mizrachi, Debby Reuveni, Sara Fuchs

Ann N Y Acad Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Revital Aricha, Tali Feferman, Sonia Berrih-Aknin, Sara Fuchs, Miriam C Souroujon

Ann N Y Acad Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Revital Aricha, Keren Mizrachi, Sara Fuchs, Miriam C Souroujon

J Autoimmun· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells.
Revital Aricha, Tali Feferman, Hamish S Scott, Miriam C Souroujon, Sonia Berrih-Aknin, Sara Fuchs

J Autoimmun· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of phosphodiesterases in autoimmune diseases.
Keren Mizrachi, Revital Aricha, Tali Feferman, Neta Kela-Madar, Ilana Mandel, Sara Fuchs

J Neuroimmunol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
Tali Feferman, Revital Aricha, Keren Mizrachi, Erez Geron, Ronen Alon, Sara Fuchs

J Neuroimmunol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
Hwa-Jung Yi, Chang-Suk Chae, Jae-Seon So, Socrates J Tzartos, Miriam C Souroujon, Sara Fuchs

Mol Immunol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction.
Sara Fuchs, Tali Feferman, Roberto Meidler, Raanan Margalit, Camille Sicsic

Ann N Y Acad Sci· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by combination therapy: pentoxifylline as a steroid-sparing agent.
Renuka T R Menon, Tali Feferman, Revital Aricha, Miriam C Souroujon, Sara Fuchs

J Neuroimmunol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.
Sara Fuchs, Tali Feferman, Roberto Meidler, Raanan Margalit, Camille Sicsic

J Neuroimmunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis.
Revital Aricha, Tali Feferman, Sara Fuchs, Miriam C Souroujon

J Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
Sara Fuchs, Tali Feferman, Roberto Meidler, Talma Brenner, Orgad Laub

Isr Med Assoc J· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
Sara Fuchs, Tali Feferman, Kai-Yun Zhu, Roberto Meidler, Raanan Margalit

Ann N Y Acad Sci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA microarray in search of new drug targets for myasthenia gravis.
Tali Feferman, Revital Aricha, Renuka Menon, Miriam C Souroujon, Sonia Berrih-Aknin, Sara Fuchs

Ann N Y Acad Sci· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
Kai-Yun Zhu, Tali Feferman, Prasanta K Maiti, Miriam C Souroujon, Sara Fuchs

J Neuroimmunol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low levels of alpha7-nicotinic acetylcholine receptor mRNA on peripheral blood lymphocytes in schizophrenia and its association with illness severity.
Orly Perl, Rael D Strous, Angela Dranikov, Rina Chen, Sara Fuchs

Neuropsychobiology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor.
Revital Aricha, Tali Feferman, Miriam C Souroujon, Sara Fuchs

FASEB J· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines against myasthenia gravis.
Sonia Berrih-Aknin, Sara Fuchs, Miriam C Souroujon

Expert Opin Biol Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis